Skip to content

Transcriptional pathways of definitive ALS genes implicate novel disease-associated target genes

Jul 2026 · medRxiv · 0 citations
Medicine

TL;DR

This work identifies transcriptional pathways linking variants in definitive ALS genes to widespread coordinated co-expression activity driven by gene-specific transcriptional programs, and establishes a generalizable framework that is readily applicable across heritable diseases for the identification of disease-relevant molecular pathways and target genes.

View source

Similar papers

Review Open access 2026

Gene expression in amyotrophic lateral sclerosis: an integrative narrative review of microarray findings, pathogenic mechanisms, and technical challenges

A narrative review synthesizes findings from key microarray studies, focusing on dysregulated pathways such as ribosomal function, protein synthesis, and metabolic processes within motor nerves and Schwann cells, and the emerging role of competitive endogenous RNA (ceRNA) networks.

F. Jorge · 0 citations
Review Open access Aug 2026

Circular RNAs in amyotrophic lateral sclerosis.

RNA-seq data from ALS patients confirmed significant alterations in the expression of host genes of ALS-related circRNAs and hub proteins in ALS-affected CNS tissues, and these findings identify circRNAs as potential key contributors to ALS pathogenesis.

R. Ataei, J. Amini, N. Sanadgol et al. · 0 citations
Open access Jul 2026

Gene regulatory co-expression networks decipher potential lncRNA-miRNA-mRNA interactions modulating transcription regulation in neurodegeneration

A systems-level view of transcriptomic dysregulation across major neurodegenerative diseases is provided and candidate regulatory interactions and molecular targets for future functional investigation are identified.

Amrit Venkatesan, Prashasti Sinha, J. Basak et al. · 0 citations
Open access Aug 2026

Parietal Cortex Transcriptomics Refines Parkinson Disease GWAS Nomination and Highlights STAT3 as a Putative Upstream Glial Regulator

It is suggested that integrating disease-state transcriptomics with genetic prioritization can refine PD risk-gene nomination and uncover regulatory programs that may be missed by GWAS alone.

Isabel Alfradique-Dunham, Jessie Sanford, Meng-Han Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.